Update on the Role of Adequate Vitamin D Provision for Avoiding Insulin Resistance and its Sequelae [Type 2 Diabetes and Cardiovascular Disease]
Main Article Content
Abstract
Type 2 diabetes prevalence is increasing, reaching ‘pandemic’ proportions globally, and associated with increasing obesity rates. Concomitantly, vitamin D deficiency persists world-wide and is worsened by obesity because it reduces hepatic 25-hydroxylation of vitamin D, which reduces circulating 25(OH)D availability to target tissues; these include islet beta cells, since vitamin D is essential for adequate insulin responses to hyperglycemia. Increased insulin resistance increases type-2 diabetes risks and precedes its development by decades, reflecting changes in hepatic and muscle function that are corrected experimentally by activated hormonal vitamin D [calcitriol]; similarly, abnormal insulin resistance can be corrected in humans by correcting vitamin D deficiency using oral supplementation. Since vitamin D deficiency and inadequacy persist world-wide despite various guidelines on vitamin D intake, the possibility that correcting deficiency would contribute to reducing T2DM risks through beneficial effects on pancreatic islet beta cells and on the metabolic disorders contributing to insulin resistance through vitamin D inadequacy warrants consideration. If this is the case, then ensuring vitamin D adequacy in populations at high risk of Type-2 diabetes would be a valuable adjunct to other measures being taken to reduce that risk such as increased exercise and weight reduction. It would also reduce cardiovascular disease risks, well known to increase with insulin resistance, with or without concomitant Type-2 diabetes. Cardiovascular disease risks themselves can be reduced by adequately correcting deficiency and are lower with higher lifetime circulating 25-hydroxyvitamin D in deficient subjects from Mendelian randomization analysis. This report, therefore, reviews the evidence for increased insulin resistance as a risk factor for Type-2 diabetes, the beneficial effects of correcting vitamin deficiency on insulin resistance, Type-2 diabetes and cardiovascular risks, some basic mechanisms accounting for those benefits, the reasons for the persistence of vitamin D inadequacy globally and how best that problem could be corrected.
Article Details
How to Cite
BOUCHER, Barbara J.
Update on the Role of Adequate Vitamin D Provision for Avoiding Insulin Resistance and its Sequelae [Type 2 Diabetes and Cardiovascular Disease].
Medical Research Archives, [S.l.], v. 11, n. 5, may 2023.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/3792>. Date accessed: 04 dec. 2024.
doi: https://doi.org/10.18103/mra.v11i5.3792.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980 Aug 15;209(4458):823-5. doi: 10.1126/science.6250216.
2. Clark SA, Stumpf WE, Sar M, DeLuca HF, Tanaka Y. Target cells for 1,25 dihydroxyvitamin D3 in the pancreas. Cell Tissue Res. 1980;209(3):515-20. doi: 10.1007/BF00234764.
3. Kadowaki S, Norman AW. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 1985;34(4):315-20.
4. Verhoeven GF, Wilson JD. The syndromes of primary hormone resistance. Metabolism. 1979 Mar;28(3):253-89. doi: 10.1016/0026-0495(79)90072-6.
5. Tinajero MG, Malik VS. An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. Endocrinol Metab Clin North Am. 2021Sep;50(3):337-355. doi: 10.1016/j.ecl.2021.05.013.
6. Perng W, Conway R, Mayer-Davis E, Dabelea D. Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic. Diabetes Care. 2023 Mar 1;46(3):490-499. doi: 10.2337/dci22-0046.
7. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017 Jun 3;389(10085):2239-2251.doi:10.1016/S0140-6736(17)30058-2.
8. Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936. Int J Epidemiol. 2013 Dec;42(6):1594-8. doi: 10.1093/ije/dyt203.
9. Himsworth. The syndrome of diabetes mellitus and its causes. Lancet. 1949 Mar 19;1(6551):465-73. doi: 10.1016/s0140-6736(49)90797-7
10. Jorge de Faria Maraschin, 2013 pubmed.ncbi.nlm.nih.gov/23393666/ [The first worldwide accepted classification scheme for DM was published in 1979 by the National Diabetes Data Group (NDDG) and classified DM based on the pharmacologic therapy applied into two major groups: Insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM).]
11. Hulman A, Simmons RK, Brunner EJ, Witte DR, Færch K, Vistisen D, et al. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia 2017;60(7):1252-1260.
12. Wu F, Juonala M, Pitkänen N, Jula A, Lehtimäki T, Sabin MA, et al. Both youth and long-term vitamin D status is associated with risk of type 2 diabetes mellitus in adulthood: a cohort study. Ann Med 2018;50(1):74-82
13. Sagesaka H, Sato Y, Someya Y, Tamura Y, Shimodaira M, Miyakoshi T, et al. Type 2 Diabetes: When Does It Start? J Endocr Soc 2018 Sagesaka H, Sato Y, Someya Y, Tamura Y, Shimodaira M, Miyakoshi T, et al. Type 2 Diabetes: When Does It Start? J Endocr Soc 2018;2(5):476-484.
14. Morgante G, Darino I, Spanò A, Luisi S, Luddi A, Piomboni P, et al. PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment. J Clin Med. 2022 Aug 2;11(15):4509. doi: 10.3390/jcm11154509.
15. Boucher BJ. Re Niroomand M, Fotouhi A, Irannejad N et al. Does high-dose vitamin D supplementation impact insulin resistance and risk of development of diabetes in patients with pre-diabetes? A double-blind randomized controlled trial. Diabetes Res Clin Pract. 2019;148:1-9. Diabetes Res Clin Pract. 2019 Sep;155:107782. doi: 10.1016/j.diabres.2019.107782. Epub 2019 Jul 17.
16. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985). https://doi.org/10.1007/BF00280883
17. Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obesity (Silver Spring). 2022 Aug;30(8):1549-1563. doi: 10.1002/oby.23503. PMID: 35894085; PMCI.
18. Tokarz VL, MacDonald PE, Klip A. The cell biology of systemic insulin function. J Cell Biol. 2018 Jul 2;217(7):2273-2289. doi: 10.1083/jcb.201802095. Epub 2018 Apr 5. PMID: 29622564; PMCID: PMC6028526.
19. Cheng Q, Li YC, Boucher BJ, Leung PS. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia 2011;54(8):2077-81.
20. Cheng S, So WY, Zhang D, Cheng Q, Boucher BJ, Leung PS. Calcitriol Reduces Hepatic Triglyceride Accumulation and Glucose Output Through Ca2+/CaMKKβ/AMPK Activation Under Insulin-Resistant Conditions in Type 2 Diabetes Mellitus. Curr Mol Med. 2016;16(8):747-758. doi: 10.2174/1566524016666160920111407.
21. Von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a double-blind randomised controlled trial. Br J Nutr 2010;1034:549- 55.
22. Chen S, Villalta SA, Agrawal DK. FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle. J Bone Miner Res. 2016 Mar;31(3):585-95. doi: 10.1002/jbmr.2729. Epub 2015 Nov 9. PMID: 26462119; PMCID: PMC4814301.
23. Alkharfy KM, Al-Daghri NM, Yakout SM, Hussain T, Mohammed AK, Krishnaswamy S. Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes. Metab Syndr Relat Disord. 2013 Aug;11(4):283-8. doi: 10.1089/met.2012.0068.
24. Holick MF. Ultraviolet B Radiation: The Vitamin D Connection. Adv Exp Med Biol. 2017;996:137-154. doi: 10.1007/978-3-319-56017-5_12.
25. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. doi: 10.1056/NEJMra070553.
26. Kühn J, Schröter A, Hartmann BM, Stangl GI. Cocoa and chocolate are sources of vitamin D2. Food Chem. 2018 Dec 15;269:318-320. doi: 10.1016/j.foodchem.2018.06.098.
27. Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci. 2018 Oct;1430(1):44-79. doi: 10.1111/nyas.13968.
28. Makris K, Bhattoa HP, Cavalier E, Phinney K, Sempos CT, Ulmer CZ, et al. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism. Clin Chim Acta. 2021 Jun;517:171-197. doi: 10.1016/j.cca.2021.03.002.
29. DeLuca HF. The kidney as an endocrine organ involved in the function of vitamin D. Am J Med. 1975 Jan;58(1):39-47. doi: 10.1016/0002-9343(75)90531-8. PMID: 163578.
30. Adams JS, Rafison B, Witzel S, Reyes RE, Shieh A, Chun R, et al. Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:22-7. doi: 10.1016/j.jsbmb.2013.12.009.
31. Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. 1960. Obes Res. 1996 Nov;4(6):583-600. doi: 10.1002/j.1550-8528.1996.tb00274.x.
32. Coldwell RD, Trafford DJ, Varley MJ, Kirk DN, Makin HL. Measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D2 and 25,26-dihydroxyvitamin D2 in a single plasma sample by mass fragmentography. Clin Chim Acta. 1989 Feb 28;180(2):157-68. doi: 10.1016/0009-8981(89)90347-1.
33. Carter GD, Berry J, Durazo-Arvizu R, Gunter E, Jones G, Jones J, Makin HLJ, Pattni P, Sempos CT, Twomey P, Williams EL, Wise SA. Hydroxyvitamin D assays: An historical perspective from DEQAS. J Steroid Biochem Mol Biol. 2018 Mar;177:30-35. doi: 10.1016/j.jsbmb.2017.07.018.
34. Carlberg C. Vitamin D Genomics: From In Vitro to In Vivo. Front Endocrinol (Lausanne). 2018 May 23;9:250. doi: 10.3389/fendo.2018.00250.
35. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995 Aug;17(2 Suppl):33S-38S. doi: 10.1016/8756-3282(95)00205-r.
36. Hii CS, Ferrante A. The Non-Genomic Actions of Vitamin D. Nutrients. 2016 Mar 2;8(3):135. doi: 10.3390/nu8030135.
37. Wu YL, Lin ZJ, Li CC, Lin X, Shan SK, Guo B, et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023 Mar 2;8(1):98. doi: 10.1038/s41392-023-01333-7.
38. Godfrey KM, Costello PM, Lillycrop KA. Development, Epigenetics and Metabolic Programming. Nestle Nutr Inst Workshop Ser. 2016;85:71-80. doi: 10.1159/000439488.
39. Griffin G, Hewison M, Hopkin J, Kenny RA, Quinton R, Rhodes J, et al. Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19. Clin Med (Lond). 2021 Mar;21(2):e144-e149. doi: 10.7861/clinmed.2021-0035.
40. Scientific Advisory Committee on Nutrition (SACN). Vitamin D and health. 2016. https://www.gov.uk/government/groups/scientific-advisory-committee-on-nutrition. Viewed 7th March 2023
41. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press; 2011.
42. European Food Safety Authority (EFSA). Dietary reference values for vitamin D. EFSA Panel on Dietetic Products, Nutrition and Allergies. 2016. https://efsa.onlinelibrary.wiley.com/
https://doi.org/10.2903/j.efsa.2016.4547.
43. Veugelers PJ, Ekwaru JP. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients. 2014 Oct 20;6(10):4472-5. doi: 10.3390/nu6104472.
44. Kimball SM, Holick MF. Official recommendations for vitamin D through the life stages in developed countries. Eur J Clin Nutr. 2020 Nov;74(11):1514-1518. doi: 10.1038/s41430-020-00706-3.
45. Grant WB, Al Anouti F, Boucher BJ, Dursun E, Gezen-Ak D, Jude EB, et al. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health. Nutrients. 2022 Feb 2;14(3):639. doi: 10.3390/nu14030639.
46. Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6.
47. Petkovich M, Melnick J, White J, Tabash S, Strugnell S, Bishop CW. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. J Steroid Biochem Mol Biol. 2015 Apr;148:283-9. doi: 10.1016/j.jsbmb.2014.11.022. Epub 2014 Nov 22. PMID: 25446887.
48. Mehmood ZH, Papandreou D. An Updated Mini Review of Vitamin D and Obesity: Adipogenesis and Inflammation State. Open Access Maced J Med Sci. 2016 Sep 15;4(3):526-532. doi: 10.3889/oamjms.2016.103.
49. Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014 Apr 21;5:151. doi: 10.3389/fphys.2014.00151.
50. Mirza I, Mohamed A, Deen H, Balaji S, Elsabbahi D, Munasser A, et al. Obesity-Associated Vitamin D Deficiency Correlates with Adipose Tissue DNA Hypomethylation, Inflammation, and Vascular Dysfunction. Int J Mol Sci. 2022 Nov 19;23(22):14377. doi: 10.3390/ijms232214377.
51. Zhou A, Hyppönen E. Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study. Int J Epidemiol. 2023 Feb 8;52(1):260-271. doi: 10.1093/ije/dyac087.
52. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002 Dec;95(12):787-96. doi: 10.1093/qjmed/95.12.787.
53. Liu Q, Pan J, Bao L, Xu C, Qi Y, Jiang B, et al. Major Vault Protein Prevents Atherosclerotic Plaque Destabilization by Suppressing Macrophage ASK1-JNK Signaling. Arterioscler Thromb Vasc Biol. 2022 May;42(5):580-596. doi: 10.1161/ATVBAHA.121.316662
54. Sutherland JP, Zhou A, Hyppönen E. Vitamin D Deficiency Increases Mortality Risk in the UK Biobank: A Nonlinear Mendelian Randomization Study. Ann Intern Med. 2022 Nov;175(11):1552-1559. doi: 10.7326/M21-3324.
55. Zhou A, Selvanayagam JB, Hyppönen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J. 2022 May 7;43(18):1731-1739. doi: 10.1093/eurheartj/ehab809.
56. Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol. 2021 Feb 2;10:615375. doi: 10.3389/fonc.2020.615375.
57. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014 Nov 5;9(11):e111265. doi: 10.1371/journal.pone.0111265.
58. Drincic A, Fuller E, Heaney RP, Armas LA. 25-Hydroxyvitamin D response to graded vitamin D₃ supplementation among obese adults. J Clin Endocrinol Metab.2013 Dec;98(12):4845-51. doi: 10.1210/jc.2012-4103.
59. Hyppönen E, Boucher BJ. Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities. Nutr Rev. 2018 Sep 1;76(9):678-692. doi: 10.1093/nutrit/nuy034.
60. Ma Y, Johnson CS, Trump DL. Mechanistic Insights of Vitamin D Anticancer Effects. Vitam Horm. 2016;100:395-431. doi: 10.1016/bs.vh.2015.11.003.
61. Muñoz A, Grant WB. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022 Mar 30;14(7):1448. doi: 10.3390/nu14071448.
62. Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, et al. VITAL Research Group. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial. JAMA Netw Open. 2020 Nov 2;3(11):e2025850. doi: 10.1001/jamanetworkopen.2020.25850. Erratum in: JAMA Netw Open. 2020 Dec 1;3(12):e2032460. PMID: 33206192
63. Bener A, Al-Ali M, Hoffmann GF. High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr. 2009 Feb;61(1):15-22. PMID: 19179999.
64. Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci. 2018 Oct;1430(1):44-79. doi: 10.1111/nyas.13968.
65. Sutherland JP, Zhou A, Leach MJ, Hyppönen E. Differences and determinants of vitamin D deficiency among UK biobank participants: A cross-ethnic and socioeconomic study. Clin Nutr. 2021 May;40(5):3436-3447. doi: 10.1016/j.clnu.2020.11.019.
66. Barragry JM, France MW, Corless D, Gupta SP, Switala S, Boucher BJ, et al. Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin Sci Mol Med. 1978 Aug;55(2):213-20. doi: 10.1042/cs0550213.
67. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Genetic Investigation of Anthropometric Traits-GIANT Consortium; Streeten EA, Theodoratou E, Jula A, Wareham NJ, Ohlsson C, Frayling TM, et al.. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10(2):e1001383. doi: 10.1371/journal.pmed.1001383.
68. J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987 Jun;64(6):1165-8. doi: 10.1210/jcem-64-6-1165.
69. Itkonen ST, Andersen R, Björk AK, Brugård Konde Å, Eneroth H, Erkkola M, et al. Vitamin D status and current policies to achieve adequate vitamin D intake in the Nordic countries. Scand J Public Health. 2021 Aug;49(6):616-627. doi: 10.1177/1403494819896878.
70. Jääskeläinen T, Itkonen ST, Lundqvist A, Erkkola M, Koskela T, Lakkala K, et al. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am J Clin Nutr. 2017 Jun;105(6):1512-1520. doi: 10.3945/ajcn.116.151415.
71. Boucher BJ. Discrepancies between current guidance from NICE on the treatment of vitamin D deficiency and the recommended daily amounts [RDAs] for its prevention in the UK. Expert Rev Endocrinol Metab. 2022 May;17(3):201-203. doi: 10.1080/17446651.2022.2067143.
72. Moy RJ, McGee E, Debelle GD, Mather I, Shaw NJ. Successful public health action to reduce the incidence of symptomatic vitamin D deficiency. Arch Dis Child. 2012 Nov;97(11):952-4. doi: 10.1136/archdischild-2012-302287.
73. Spreadable Fats (Marketing Standards) and Milk and Milk Products (Protection of Designations) (England) Regulations 2008. Regulation 4 requires the fortification of margarine with vitamins A and D. [accessed March 7th 2023]
74. Ministry of Food and successors: Welfare Food Scheme, https://discovery.nationalarchives.gov.uk/details/r/C10953 [accessed March 7th 2023
75. Iacono JM, Dougherty RM, Puska P. Dietary fats and the management of hypertension. Can J Physiol Pharmacol. 1986 Jun;64(6):856-62. doi: 10.1139/y86-148.
76. Paalanen L, Härkänen T, Tolonen H. Protocol of a research project 'Projections of the burden of disease and disability in Finland - health policy prospects' using cross-sectional health surveys and register-based follow-up. BMJ Open. 2019 Jun 20;9(6):e029338. doi: 10.1136/bmjopen-2019-029338. PMID: 31227540
77. Dawson-Hughes B, Nelson J, Pittas AG. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922. Diabetes Care. 2021 May;44(5):e106. doi: 10.2337/dci21-0006.
78. Aguiar M, Andronis L, Pallan M, Högler W, Frew E. The economic case for prevention of population vitamin D deficiency: a modelling study using data from England and Wales. Eur J Clin Nutr. 2020 May;74(5):825-833. doi: 10.1038/s41430-019-0486-x.
79. Bejar CA, Goyal S, Afzal S, Mangino M, Zhou A, van der Most PJ, Bao Y, et al. A Bidirectional Mendelian Randomization Study to evaluate the causal role of reduced blood vitamin D levels with type 2 diabetes risk in South Asians and Europeans. Nutr J. 2021 Jul 27;20(1):71. doi: 10.1186/s12937-021-00725-1.
80. Hyppönen E, Vimaleswaran KS, Zhou A. Genetic Determinants of 25-Hydroxyvitamin D Concentrations and Their Relevance to Public Health. Nutrients. 2022 Oct 20;14(20):4408. doi: 10.3390/nu14204408.
81. Ang Zhou , Joseph B Selvanayagam , Elina Hyppönen . Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk Eur Heart J 2022 May 7;43(18):1731-1739. doi: 10.1093/eurheartj/ehab809. Non-linear DOI: 10.1093/eurheartj/ehab809
82. Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol 2021 Dec;9(12):837-846. doi: 10.1016/S2213-8587(21)00263-1.
2. Clark SA, Stumpf WE, Sar M, DeLuca HF, Tanaka Y. Target cells for 1,25 dihydroxyvitamin D3 in the pancreas. Cell Tissue Res. 1980;209(3):515-20. doi: 10.1007/BF00234764.
3. Kadowaki S, Norman AW. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 1985;34(4):315-20.
4. Verhoeven GF, Wilson JD. The syndromes of primary hormone resistance. Metabolism. 1979 Mar;28(3):253-89. doi: 10.1016/0026-0495(79)90072-6.
5. Tinajero MG, Malik VS. An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. Endocrinol Metab Clin North Am. 2021Sep;50(3):337-355. doi: 10.1016/j.ecl.2021.05.013.
6. Perng W, Conway R, Mayer-Davis E, Dabelea D. Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic. Diabetes Care. 2023 Mar 1;46(3):490-499. doi: 10.2337/dci22-0046.
7. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017 Jun 3;389(10085):2239-2251.doi:10.1016/S0140-6736(17)30058-2.
8. Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936. Int J Epidemiol. 2013 Dec;42(6):1594-8. doi: 10.1093/ije/dyt203.
9. Himsworth. The syndrome of diabetes mellitus and its causes. Lancet. 1949 Mar 19;1(6551):465-73. doi: 10.1016/s0140-6736(49)90797-7
10. Jorge de Faria Maraschin, 2013 pubmed.ncbi.nlm.nih.gov/23393666/ [The first worldwide accepted classification scheme for DM was published in 1979 by the National Diabetes Data Group (NDDG) and classified DM based on the pharmacologic therapy applied into two major groups: Insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM).]
11. Hulman A, Simmons RK, Brunner EJ, Witte DR, Færch K, Vistisen D, et al. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia 2017;60(7):1252-1260.
12. Wu F, Juonala M, Pitkänen N, Jula A, Lehtimäki T, Sabin MA, et al. Both youth and long-term vitamin D status is associated with risk of type 2 diabetes mellitus in adulthood: a cohort study. Ann Med 2018;50(1):74-82
13. Sagesaka H, Sato Y, Someya Y, Tamura Y, Shimodaira M, Miyakoshi T, et al. Type 2 Diabetes: When Does It Start? J Endocr Soc 2018 Sagesaka H, Sato Y, Someya Y, Tamura Y, Shimodaira M, Miyakoshi T, et al. Type 2 Diabetes: When Does It Start? J Endocr Soc 2018;2(5):476-484.
14. Morgante G, Darino I, Spanò A, Luisi S, Luddi A, Piomboni P, et al. PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment. J Clin Med. 2022 Aug 2;11(15):4509. doi: 10.3390/jcm11154509.
15. Boucher BJ. Re Niroomand M, Fotouhi A, Irannejad N et al. Does high-dose vitamin D supplementation impact insulin resistance and risk of development of diabetes in patients with pre-diabetes? A double-blind randomized controlled trial. Diabetes Res Clin Pract. 2019;148:1-9. Diabetes Res Clin Pract. 2019 Sep;155:107782. doi: 10.1016/j.diabres.2019.107782. Epub 2019 Jul 17.
16. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985). https://doi.org/10.1007/BF00280883
17. Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obesity (Silver Spring). 2022 Aug;30(8):1549-1563. doi: 10.1002/oby.23503. PMID: 35894085; PMCI.
18. Tokarz VL, MacDonald PE, Klip A. The cell biology of systemic insulin function. J Cell Biol. 2018 Jul 2;217(7):2273-2289. doi: 10.1083/jcb.201802095. Epub 2018 Apr 5. PMID: 29622564; PMCID: PMC6028526.
19. Cheng Q, Li YC, Boucher BJ, Leung PS. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia 2011;54(8):2077-81.
20. Cheng S, So WY, Zhang D, Cheng Q, Boucher BJ, Leung PS. Calcitriol Reduces Hepatic Triglyceride Accumulation and Glucose Output Through Ca2+/CaMKKβ/AMPK Activation Under Insulin-Resistant Conditions in Type 2 Diabetes Mellitus. Curr Mol Med. 2016;16(8):747-758. doi: 10.2174/1566524016666160920111407.
21. Von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a double-blind randomised controlled trial. Br J Nutr 2010;1034:549- 55.
22. Chen S, Villalta SA, Agrawal DK. FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle. J Bone Miner Res. 2016 Mar;31(3):585-95. doi: 10.1002/jbmr.2729. Epub 2015 Nov 9. PMID: 26462119; PMCID: PMC4814301.
23. Alkharfy KM, Al-Daghri NM, Yakout SM, Hussain T, Mohammed AK, Krishnaswamy S. Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes. Metab Syndr Relat Disord. 2013 Aug;11(4):283-8. doi: 10.1089/met.2012.0068.
24. Holick MF. Ultraviolet B Radiation: The Vitamin D Connection. Adv Exp Med Biol. 2017;996:137-154. doi: 10.1007/978-3-319-56017-5_12.
25. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. doi: 10.1056/NEJMra070553.
26. Kühn J, Schröter A, Hartmann BM, Stangl GI. Cocoa and chocolate are sources of vitamin D2. Food Chem. 2018 Dec 15;269:318-320. doi: 10.1016/j.foodchem.2018.06.098.
27. Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci. 2018 Oct;1430(1):44-79. doi: 10.1111/nyas.13968.
28. Makris K, Bhattoa HP, Cavalier E, Phinney K, Sempos CT, Ulmer CZ, et al. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism. Clin Chim Acta. 2021 Jun;517:171-197. doi: 10.1016/j.cca.2021.03.002.
29. DeLuca HF. The kidney as an endocrine organ involved in the function of vitamin D. Am J Med. 1975 Jan;58(1):39-47. doi: 10.1016/0002-9343(75)90531-8. PMID: 163578.
30. Adams JS, Rafison B, Witzel S, Reyes RE, Shieh A, Chun R, et al. Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:22-7. doi: 10.1016/j.jsbmb.2013.12.009.
31. Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. 1960. Obes Res. 1996 Nov;4(6):583-600. doi: 10.1002/j.1550-8528.1996.tb00274.x.
32. Coldwell RD, Trafford DJ, Varley MJ, Kirk DN, Makin HL. Measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D2 and 25,26-dihydroxyvitamin D2 in a single plasma sample by mass fragmentography. Clin Chim Acta. 1989 Feb 28;180(2):157-68. doi: 10.1016/0009-8981(89)90347-1.
33. Carter GD, Berry J, Durazo-Arvizu R, Gunter E, Jones G, Jones J, Makin HLJ, Pattni P, Sempos CT, Twomey P, Williams EL, Wise SA. Hydroxyvitamin D assays: An historical perspective from DEQAS. J Steroid Biochem Mol Biol. 2018 Mar;177:30-35. doi: 10.1016/j.jsbmb.2017.07.018.
34. Carlberg C. Vitamin D Genomics: From In Vitro to In Vivo. Front Endocrinol (Lausanne). 2018 May 23;9:250. doi: 10.3389/fendo.2018.00250.
35. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995 Aug;17(2 Suppl):33S-38S. doi: 10.1016/8756-3282(95)00205-r.
36. Hii CS, Ferrante A. The Non-Genomic Actions of Vitamin D. Nutrients. 2016 Mar 2;8(3):135. doi: 10.3390/nu8030135.
37. Wu YL, Lin ZJ, Li CC, Lin X, Shan SK, Guo B, et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023 Mar 2;8(1):98. doi: 10.1038/s41392-023-01333-7.
38. Godfrey KM, Costello PM, Lillycrop KA. Development, Epigenetics and Metabolic Programming. Nestle Nutr Inst Workshop Ser. 2016;85:71-80. doi: 10.1159/000439488.
39. Griffin G, Hewison M, Hopkin J, Kenny RA, Quinton R, Rhodes J, et al. Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19. Clin Med (Lond). 2021 Mar;21(2):e144-e149. doi: 10.7861/clinmed.2021-0035.
40. Scientific Advisory Committee on Nutrition (SACN). Vitamin D and health. 2016. https://www.gov.uk/government/groups/scientific-advisory-committee-on-nutrition. Viewed 7th March 2023
41. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press; 2011.
42. European Food Safety Authority (EFSA). Dietary reference values for vitamin D. EFSA Panel on Dietetic Products, Nutrition and Allergies. 2016. https://efsa.onlinelibrary.wiley.com/
https://doi.org/10.2903/j.efsa.2016.4547.
43. Veugelers PJ, Ekwaru JP. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients. 2014 Oct 20;6(10):4472-5. doi: 10.3390/nu6104472.
44. Kimball SM, Holick MF. Official recommendations for vitamin D through the life stages in developed countries. Eur J Clin Nutr. 2020 Nov;74(11):1514-1518. doi: 10.1038/s41430-020-00706-3.
45. Grant WB, Al Anouti F, Boucher BJ, Dursun E, Gezen-Ak D, Jude EB, et al. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health. Nutrients. 2022 Feb 2;14(3):639. doi: 10.3390/nu14030639.
46. Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6.
47. Petkovich M, Melnick J, White J, Tabash S, Strugnell S, Bishop CW. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. J Steroid Biochem Mol Biol. 2015 Apr;148:283-9. doi: 10.1016/j.jsbmb.2014.11.022. Epub 2014 Nov 22. PMID: 25446887.
48. Mehmood ZH, Papandreou D. An Updated Mini Review of Vitamin D and Obesity: Adipogenesis and Inflammation State. Open Access Maced J Med Sci. 2016 Sep 15;4(3):526-532. doi: 10.3889/oamjms.2016.103.
49. Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014 Apr 21;5:151. doi: 10.3389/fphys.2014.00151.
50. Mirza I, Mohamed A, Deen H, Balaji S, Elsabbahi D, Munasser A, et al. Obesity-Associated Vitamin D Deficiency Correlates with Adipose Tissue DNA Hypomethylation, Inflammation, and Vascular Dysfunction. Int J Mol Sci. 2022 Nov 19;23(22):14377. doi: 10.3390/ijms232214377.
51. Zhou A, Hyppönen E. Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study. Int J Epidemiol. 2023 Feb 8;52(1):260-271. doi: 10.1093/ije/dyac087.
52. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002 Dec;95(12):787-96. doi: 10.1093/qjmed/95.12.787.
53. Liu Q, Pan J, Bao L, Xu C, Qi Y, Jiang B, et al. Major Vault Protein Prevents Atherosclerotic Plaque Destabilization by Suppressing Macrophage ASK1-JNK Signaling. Arterioscler Thromb Vasc Biol. 2022 May;42(5):580-596. doi: 10.1161/ATVBAHA.121.316662
54. Sutherland JP, Zhou A, Hyppönen E. Vitamin D Deficiency Increases Mortality Risk in the UK Biobank: A Nonlinear Mendelian Randomization Study. Ann Intern Med. 2022 Nov;175(11):1552-1559. doi: 10.7326/M21-3324.
55. Zhou A, Selvanayagam JB, Hyppönen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J. 2022 May 7;43(18):1731-1739. doi: 10.1093/eurheartj/ehab809.
56. Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol. 2021 Feb 2;10:615375. doi: 10.3389/fonc.2020.615375.
57. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014 Nov 5;9(11):e111265. doi: 10.1371/journal.pone.0111265.
58. Drincic A, Fuller E, Heaney RP, Armas LA. 25-Hydroxyvitamin D response to graded vitamin D₃ supplementation among obese adults. J Clin Endocrinol Metab.2013 Dec;98(12):4845-51. doi: 10.1210/jc.2012-4103.
59. Hyppönen E, Boucher BJ. Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities. Nutr Rev. 2018 Sep 1;76(9):678-692. doi: 10.1093/nutrit/nuy034.
60. Ma Y, Johnson CS, Trump DL. Mechanistic Insights of Vitamin D Anticancer Effects. Vitam Horm. 2016;100:395-431. doi: 10.1016/bs.vh.2015.11.003.
61. Muñoz A, Grant WB. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022 Mar 30;14(7):1448. doi: 10.3390/nu14071448.
62. Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, et al. VITAL Research Group. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial. JAMA Netw Open. 2020 Nov 2;3(11):e2025850. doi: 10.1001/jamanetworkopen.2020.25850. Erratum in: JAMA Netw Open. 2020 Dec 1;3(12):e2032460. PMID: 33206192
63. Bener A, Al-Ali M, Hoffmann GF. High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr. 2009 Feb;61(1):15-22. PMID: 19179999.
64. Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci. 2018 Oct;1430(1):44-79. doi: 10.1111/nyas.13968.
65. Sutherland JP, Zhou A, Leach MJ, Hyppönen E. Differences and determinants of vitamin D deficiency among UK biobank participants: A cross-ethnic and socioeconomic study. Clin Nutr. 2021 May;40(5):3436-3447. doi: 10.1016/j.clnu.2020.11.019.
66. Barragry JM, France MW, Corless D, Gupta SP, Switala S, Boucher BJ, et al. Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin Sci Mol Med. 1978 Aug;55(2):213-20. doi: 10.1042/cs0550213.
67. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Genetic Investigation of Anthropometric Traits-GIANT Consortium; Streeten EA, Theodoratou E, Jula A, Wareham NJ, Ohlsson C, Frayling TM, et al.. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10(2):e1001383. doi: 10.1371/journal.pmed.1001383.
68. J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987 Jun;64(6):1165-8. doi: 10.1210/jcem-64-6-1165.
69. Itkonen ST, Andersen R, Björk AK, Brugård Konde Å, Eneroth H, Erkkola M, et al. Vitamin D status and current policies to achieve adequate vitamin D intake in the Nordic countries. Scand J Public Health. 2021 Aug;49(6):616-627. doi: 10.1177/1403494819896878.
70. Jääskeläinen T, Itkonen ST, Lundqvist A, Erkkola M, Koskela T, Lakkala K, et al. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am J Clin Nutr. 2017 Jun;105(6):1512-1520. doi: 10.3945/ajcn.116.151415.
71. Boucher BJ. Discrepancies between current guidance from NICE on the treatment of vitamin D deficiency and the recommended daily amounts [RDAs] for its prevention in the UK. Expert Rev Endocrinol Metab. 2022 May;17(3):201-203. doi: 10.1080/17446651.2022.2067143.
72. Moy RJ, McGee E, Debelle GD, Mather I, Shaw NJ. Successful public health action to reduce the incidence of symptomatic vitamin D deficiency. Arch Dis Child. 2012 Nov;97(11):952-4. doi: 10.1136/archdischild-2012-302287.
73. Spreadable Fats (Marketing Standards) and Milk and Milk Products (Protection of Designations) (England) Regulations 2008. Regulation 4 requires the fortification of margarine with vitamins A and D. [accessed March 7th 2023]
74. Ministry of Food and successors: Welfare Food Scheme, https://discovery.nationalarchives.gov.uk/details/r/C10953 [accessed March 7th 2023
75. Iacono JM, Dougherty RM, Puska P. Dietary fats and the management of hypertension. Can J Physiol Pharmacol. 1986 Jun;64(6):856-62. doi: 10.1139/y86-148.
76. Paalanen L, Härkänen T, Tolonen H. Protocol of a research project 'Projections of the burden of disease and disability in Finland - health policy prospects' using cross-sectional health surveys and register-based follow-up. BMJ Open. 2019 Jun 20;9(6):e029338. doi: 10.1136/bmjopen-2019-029338. PMID: 31227540
77. Dawson-Hughes B, Nelson J, Pittas AG. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922. Diabetes Care. 2021 May;44(5):e106. doi: 10.2337/dci21-0006.
78. Aguiar M, Andronis L, Pallan M, Högler W, Frew E. The economic case for prevention of population vitamin D deficiency: a modelling study using data from England and Wales. Eur J Clin Nutr. 2020 May;74(5):825-833. doi: 10.1038/s41430-019-0486-x.
79. Bejar CA, Goyal S, Afzal S, Mangino M, Zhou A, van der Most PJ, Bao Y, et al. A Bidirectional Mendelian Randomization Study to evaluate the causal role of reduced blood vitamin D levels with type 2 diabetes risk in South Asians and Europeans. Nutr J. 2021 Jul 27;20(1):71. doi: 10.1186/s12937-021-00725-1.
80. Hyppönen E, Vimaleswaran KS, Zhou A. Genetic Determinants of 25-Hydroxyvitamin D Concentrations and Their Relevance to Public Health. Nutrients. 2022 Oct 20;14(20):4408. doi: 10.3390/nu14204408.
81. Ang Zhou , Joseph B Selvanayagam , Elina Hyppönen . Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk Eur Heart J 2022 May 7;43(18):1731-1739. doi: 10.1093/eurheartj/ehab809. Non-linear DOI: 10.1093/eurheartj/ehab809
82. Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol 2021 Dec;9(12):837-846. doi: 10.1016/S2213-8587(21)00263-1.